• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of ketamine on the dynorphin levels and the ethylketocyclazocine (EKC) receptor binding in discrete regions of rat brains.

作者信息

Pongdhana K, Ogawa N, Hirose Y, Ohara S, Kosaka F, Tachibana S

出版信息

Neurochem Res. 1985 Jul;10(7):945-52. doi: 10.1007/BF00964631.

DOI:10.1007/BF00964631
PMID:2864646
Abstract

Intraperitoneal (ip) injection of ketamine increased the concentration of dynorphin in the cortex of rat brain, while decreased it in the septal area. The affinity of ethylketocyclazocine (EKC) receptor binding was decreased in the cortex, but increased in the septal area after pretreating the rats with ketamine. This suggests that the dynorphin neuronal system is stimulated in the cortex and suppressed in the septal area by ketamine. In other 5 brain areas, ketamine had no effect on neither dynorphin concentration nor EKC receptor binding. As dynorphin was reported to produce seizure and spike discharge in the cortex while suppressed the hippocampal EEG of rat brain, it is likely that the dynorphin neuronal system may play at least a part in ketamine induced electrophysiological changes in the brain.

摘要

相似文献

1
Effects of ketamine on the dynorphin levels and the ethylketocyclazocine (EKC) receptor binding in discrete regions of rat brains.
Neurochem Res. 1985 Jul;10(7):945-52. doi: 10.1007/BF00964631.
2
Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.κ1和κ2阿片受体介导大鼠新纹状体中多巴胺和乙酰胆碱释放的突触前抑制。
Br J Pharmacol. 1997 Oct;122(3):520-4. doi: 10.1038/sj.bjp.0701394.
3
Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.强啡肽A-(1-13)-酪氨酰14-亮氨酰15-苯丙氨酰16-天冬酰胺17-甘氨酰18-脯氨酰19:一种强效且选择性的κ阿片肽。
Eur J Pharmacol. 1991 Apr 17;196(2):161-7. doi: 10.1016/0014-2999(91)90423-n.
4
Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.使用强啡肽A1-13和U69,593对大鼠脑内κ阿片受体结合进行表征
J Pharmacol Exp Ther. 1990 May;253(2):749-59.
5
Electrophysiological evidence for kappa-agonist activity of dynorphin in rat brain.
Neuropharmacology. 1984 Feb;23(2A):207-10. doi: 10.1016/s0028-3908(84)80016-7.
6
Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.κ阿片受体激动剂强啡肽-(1-13)和乙基酮环唑新对麻醉大鼠的中枢心血管效应
Eur J Pharmacol. 1983 Dec 9;96(1-2):165-9. doi: 10.1016/0014-2999(83)90547-2.
7
Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.在经过训练以区分阿片κ受体激动剂乙基酮环唑新的大鼠中,对脑室内注射前脑啡肽B衍生肽进行的泛化测试。
Psychopharmacology (Berl). 1985;85(4):440-3. doi: 10.1007/BF00429661.
8
Evidence for kappa 1 opioid receptor multiplicity in the guinea pig cerebellum.豚鼠小脑中κ1阿片受体多样性的证据。
Eur J Pharmacol. 1991 Jun 19;207(2):135-41. doi: 10.1016/0922-4106(91)90088-y.
9
Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
Neuropharmacology. 1987 Aug;26(8):1141-6. doi: 10.1016/0028-3908(87)90260-7.
10
[3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
Life Sci. 1988;42(23):2403-12. doi: 10.1016/0024-3205(88)90195-6.

引用本文的文献

1
Effects of ketamine on the cholecystokinin, somatostatin, substance P, and thyrotropin releasing hormone in discrete regions of rat brain.氯胺酮对大鼠脑不同区域胆囊收缩素、生长抑素、P物质及促甲状腺激素释放激素的影响。
Neurochem Res. 1987 Jan;12(1):73-7. doi: 10.1007/BF00971367.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.新型分离麻醉药CI - 581对人体的药理作用
Clin Pharmacol Ther. 1965 May-Jun;6:279-91. doi: 10.1002/cpt196563279.
3
The involvement of opiate and monoaminergic neuronal systems in the analgesic effects of ketamine.阿片类和单胺能神经元系统在氯胺酮镇痛作用中的参与。
Pain. 1982 Jan;12(1):57-73. doi: 10.1016/0304-3959(82)90170-1.
4
Opiate receptor mediation of ketamine analgesia.氯胺酮镇痛的阿片受体介导作用。
Anesthesiology. 1982 Apr;56(4):291-7. doi: 10.1097/00000542-198204000-00011.
5
Discrete regional distributions of thyrotropin releasing hormone (TRH) receptor binding in monkey central nervous system.促甲状腺激素释放激素(TRH)受体结合在猴中枢神经系统中的离散区域分布。
Brain Res. 1981 Jan 26;205(1):169-74. doi: 10.1016/0006-8993(81)90728-9.
6
The interaction of ketamine with the opiate receptor.氯胺酮与阿片受体的相互作用。
Life Sci. 1980 Mar 10;26(10):789-95. doi: 10.1016/0024-3205(80)90285-4.
7
Ketamine and the guinea-pig ileum: possible opiate agonist and antagonist actions and effects of peptidase inhibition.氯胺酮与豚鼠回肠:可能的阿片类激动剂和拮抗剂作用以及肽酶抑制的影响
J Pharmacol Exp Ther. 1983 Apr;225(1):206-12.
8
Multiple forms of immunoreactive dynorphin in human pituitary and pheochromocytoma.
Life Sci. 1983 Feb 21;32(8):865-70. doi: 10.1016/0024-3205(83)90223-0.
9
Dynorphin (1-17): lack of analgesia but evidence for non-opiate electrophysiological and motor effects.强啡肽(1-17):无镇痛作用,但有非阿片类电生理和运动效应的证据。
Life Sci. 1982;31(16-17):1821-4. doi: 10.1016/0024-3205(82)90219-3.
10
Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.强啡肽及其肽片段对豚鼠回肠的κ阿片样物质特性
J Pharmacol Exp Ther. 1982 Jul;222(1):71-9.